Chelsea Counsel Company’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-650
| Closed | -$3K | – | 89 |
|
2016
Q3 | $3K | Hold |
650
| – | – | ﹤0.01% | 88 |
|
2016
Q2 | $6K | Sell |
650
-50
| -7% | -$462 | ﹤0.01% | 95 |
|
2016
Q1 | $8K | Hold |
700
| – | – | ﹤0.01% | 126 |
|
2015
Q4 | $10K | Hold |
700
| – | – | ﹤0.01% | 135 |
|
2015
Q3 | $12K | Hold |
700
| – | – | ﹤0.01% | 156 |
|
2015
Q2 | $13K | Hold |
700
| – | – | ﹤0.01% | 159 |
|
2015
Q1 | $14K | Hold |
700
| – | – | ﹤0.01% | 137 |
|
2014
Q4 | $20K | Hold |
700
| – | – | ﹤0.01% | 134 |
|
2014
Q3 | $25K | Hold |
700
| – | – | 0.01% | 131 |
|
2014
Q2 | $31K | Hold |
700
| – | – | 0.01% | 124 |
|
2014
Q1 | $34K | Hold |
700
| – | – | 0.01% | 121 |
|
2013
Q4 | $26K | Hold |
700
| – | – | 0.01% | 110 |
|
2013
Q3 | $72K | Hold |
700
| – | – | 0.01% | 111 |
|
2013
Q2 | $54K | Buy |
+700
| New | +$54K | 0.01% | 101 |
|